-
1Academic Journal
Authors: D. V. Petrachkov, E. N. Korobov, D. D. Arzhukhanov, Д. В. Петрачков, Е. Н. Коробов, Д. Д. Аржуханов
Source: Ophthalmology in Russia; Том 18, № 3S (2021); 718-726 ; Офтальмология; Том 18, № 3S (2021); 718-726 ; 2500-0845 ; 1816-5095 ; 10.18008/1816-5095-2021-3S
Subject Terms: анти-VEGF-терапия, nonproliferative diabetic retinopathy, proliferative diabetic retinopathy, diabetic macular edema, DME, neovascularization of the retina, neovascularization of the optic nerve, vitrectomy, vitreoretinal surgery, laser coagulation of the retina, endothelial growth factor, VEGF, anti-VEGF therapy, непролиферативная диабетическая ретинопатия, пролиферативная диабетическая ретинопатия, диабетический макулярный отек, ДМО, неоваскуляризация сетчатки, неоваскуляризация зрительного нерва, витрэктомия, витреоретинальная хирургия, лазерная коагуляция сетчатки, эндотелиальный фактор роста сосудов, интравитреальные инъекции
File Description: application/pdf
Relation: https://www.ophthalmojournal.com/opht/article/view/1649/890; International Diabetes Federation. IDF Diabetes Atlas. 9th ed; 2019.; Lee R., Wong T.Y., Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17. DOI:10.1186/s40662-015-0026-2; WHO. Global Report on Diabetes; 2016:88. https://www.who.int/publications/i/item/9789241565257; Yau J., Rogers S., Kawasaki R. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–564. DOI:10.2337/dc11-1909; International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels:IDF; 2017.; Липатов Д.В., Викулова О.К., Железнякова А.В. Эпидемиология диабетической ретинопатии в Российской Федерации по данным федерального регистра пациентов с сахарным диабетом (2013–2016 гг.). Сахарный диабет. 2018;21(4):230–240. DOI:10.14341/DM9797; Дедов И.И., Шестакова М.В., Майоров А.Ю. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Сахарный диабет. 2017;20(1S):1–121. DOI:10.14341/DM20171S8; Maniadakis N., Konstantakopoulou E. Cost effectiveness of treatments for diabetic retinopathy: a systematic literature review. PharmacoEconomics. 2019;37(8):995– 1010. Accessed April 22, 2019. DOI:10.1007/s40273-019-00800-w; Здравоохранение в России. Под ред. Шаповала И.Н., Никитиной С.Ю. М.: Росстат; 2019.; Дедов И.И., Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета. Сахарный диабет. 2017;20(1):13–41. DOI:10.14341/DM8664; Simo-Servat O., Hernandez C., Simo R. Diabetic retinopathy in the context of patients with diabetes. Ophthalmic Research. 2019;62(4):211–217. DOI:10.1159/000499541; Ивахненко О.И., Нероев В.В., Зайцева О.В. Возрастная макулярная дегенерация и диабетическое поражение глаз. Социально-экономические аспекты заболеваемости. Вестник офтальмологии. 2021;137(1):123–129. DOI:10.17116/oftalma2021137011123; Stitt A., Curtis T., Chen M. The progress in understanding and treatment of diabetic retinopathy. Progress in Retinal and Eye Research. 2016;51:156–186. DOI:10.1016/j.preteyeres.2015.08.001; Ting D., Cheung G., Wong T. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clinical & Experimental Ophthalmology. 2016;44(4):260–277. DOI:10.1111/ceo.12696; Mansour S., Browning D., Wong K. The Evolving Treatment of Diabetic Retinopathy. Clinical Ophthalmology. 2020;14:653–678. Accessed March 19, 2020. DOI:10.2147/OPTH.S236637; Gupta V., Fernando J. Arevalo. Surgical Management of Diabetic Retinopathy. Middle East African Journal of Ophthalmology. 2013;20(4):283–292. DOI:10.410309749233.120003; Lin J., Chang J., Yannuzzi N. Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy. Ophthalmology. 2018;125(9):1393–1400. DOI:10.1016/j.ophtha.2018.02.038; Nawaza I., Rezzolaa S., Cancarini A. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications. Progress in Retinal and Eye Research. 2019;72:100756. DOI:10.1016/j.preteyeres.2019.03.002; The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90(2):121–125. DOI:10.1016/s0161-6420(83)34588-7; Hernández C., Simó-Servat A., Bogdanov P., Simó R. Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms. Journal of Endocrinological Investigation. 2017;40(9):925–935. DOI:10.1007/s40618-017-0648-4; Van Geest R., Lesnik-Oberstein S., Tan H. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol. 2012;96(4):587–590. DOI:10.1136/bjophthalmol-2011-301005; Балашевич Л.И., Измайлова А.С. Диабетическая офтальмопатия. СПб.: Человек; 2012.; Cunha-Vaz J. Mechanisms of retinal fluid accumulation and blood-retinal barrier breakdown. Dev. Ophthalmol. 2017;58:11–20. DOI:10.1159/000455265; Coscas G., Cunha-Vaz J., Soubrane G. Macular edema: defnition and basic concepts. Dev. Ophthalmol. 2017;58:1–10. DOI:10.1159/000455264; Zhang X., Zeng H., Bao S. Diabetic macular edema: new concepts in pathophysiology and treatment. Cell Biosci. 2014;4:27. Accessed May 14, 2014. DOI:10.1186/2045-3701-4-27; Daruich A., Matet A., Moulin A. Mechanisms of macular edema: beyond the surface. Prog. Retin. Eye Res. 2018;63:20–68. DOI:10.1016/j.preteyeres.2017.10.006; The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. American Journal of Ophthalmology. 1976;81:383–396. DOI:10.1016/0002-9394(76)90292-0; Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991;98(5Suppl):766–785. DOI:10.1016/S0161-6420 (13)38011-7; Suzuki Y., Adachi K., Maeda N. Proliferative diabetic retinopathy without preoperative pan-retinal photocoagulation is associated with higher levels of intravitreal IL-6 and postoperative infammation. International Journal of Retina and Vitreous. 2020;6:24. Accessed June 8, 2020. DOI:10.1186/s40942-020-00222-3; Будзинская М.В., Плюхова А.А., Торопыгин С.Г. Современный взгляд на лечение экссудативной формы возрастной макулярной дегенерации. Вестник офтальмологии. 2019;135(5):107–115. DOI:10.17116/oftalma2019135051107; Ip M.S., Domalpally A., Sun J.K., Ehrlich J.S. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and base-line risk factors for worsening retinopathy. Ophthalmology. 2015;122(2):367–374. DOI:10.1016/j.ophtha.2014.08.048; Bressler S., Odia I., Glassman A. Changes in diabetic retinopathy severity when treating diabetic macular edema with ranibizumab: DRCR. Net protocol I 5-year report. Retina. 2018;38(10):1896–1904. DOI:10.1097/IAE.0000000000002302; Wang D., Zhao X., Zhang W. Perioperative anti‑vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network meta-analysis. Scientifc Reports. 2020;10(1):18880. Accessed November 3, 2020. DOI: /10.1038/s41598-020-75896-8; Tan Y., Fukutomi A., Sun M. Anti-VEGF Crunch Syndrome in Proliferative Diabetic Retinopathy: A Review. Surv Ophthalmol. 2021;S0039-6257(21)00074-6. Accessed March 8, 2021. DOI:10.1016/j.survophthal.2021.03.001; Jiang T., Gu J., Zhang P. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study. BMC Ophthalmol. 2020;20(1):43. DOI:10.1186/s12886-020-1321-9; Antoszyk A., Glassman A., Beaulieu W. DRCR Retina Network. Effect of intravitreous aflibercept vs vitrectomy with panretinal photocoagulation on visual acuity in patients with vitreous hemorrhage from proliferative diabetic retinopathy: A Randomized Clinical Trial. JAMA. 2020;324(23):2383–2395. DOI:10.1001/jama.2020.23027; Maturi R., Glassman A., Liu D. Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: a DRCR network phase 2 randomized clinical trial. JAMA Ophthalmol. 2018;136(1):29–38. DOI:10.1001/jamaophthalmol.2017.4914; Iglicki M., Zur D., Busch C. Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the ‘DR-Pro-DEX Study’. Acta Diabetol. 2018;55:541–547. DOI:10.1007/s00592-018-1117-z; Wykoff C., Chakravarthy U., Campochiaro P. Long-term effects of intravitreal 0.19 mg fluocinolone acetonide implant on progression and regression of diabetic retinopathy. Ophthalmology. 2017;124(4):440–449. DOI:10.1016/j.ophtha.2016.11.034; Pessoa B., Coelho J., Correia N. Fluocinolone acetonide intravitreal implant 190 mug (ILUVIEN(R)) in vitrectomized versus nonvitrectomized eyes for the treatment of chronic diabetic macular edema. Ophthalmic Res. 2018;59(2):68–75. DOI:10.1159/000484091; Gross J., Glassman A., Jampol L. Writing Committee for the Diabetic Retinopathy Clinical Research N. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015;314(20):2137–2146. DOI:10.1001/jama.2015.15217; Wubben T., Johnson M. Anti-VEGF Treatment Interruption Study Group. AntiVEGF therapy for diabetic retinopathy: consequences of inadvertent treatment interruptions. Am J Ophthalmol. 2019;204:13–18. DOI:10.1016/j.ajo.2019.03.005; Machemer R., Buettner H., Norton E., Parel J. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol. 1971;75(4):813–820.; Khan M., Kuley A., Riemann C. Long-term visual outcomes and safety profile of 27-gauge pars plana vitrectomy for posterior segment disease. Ophthalmology. 2018;125(3):423–431. DOI:10.1016/j.ophtha.2017.09.013; Yokota R., Inoue M., Itoh Y. Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy. Jpn J Ophthalmol. 2015;59(5):288–294. DOI:10.1007/s10384-015-0396-y; Rizzo S., Fantoni G., Mucciolo D. Ultrasound in vitrectomy an alternative approach to traditional vitrectomy techniques. Retina. 2020;40(1):24–32. DOI:10.1097/IAE.0000000000002354; Berrocal M., Acaba L., Chenworth M. Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy. Current Diabetes Reports. 2019;19(10):106. Accessed September 16, 2019. DOI:10.1007/s11892-019-1210-x; Smiddy W., Flynn H. Vitrectomy in the management of diabetic retinopathy. Surv Ophthalmol. 1999;43(6):491–507. DOI:10.1016/s0039-6257(99)00036-3; The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. Arch Ophthalmol. 1985;103:1644–1652.; Browning D., Lee C., Stewart M., Landers M. Vitrectomy for center-involved diabetic macular edema. Clin Ophthalmol. 2016;10:735–742. DOI:10.2147/OPTH.S104906; Silva P., Diala P., Hamam R. Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes. Retina. 2014;34(10):1960–1968. DOI:10.1097/IAE.0000000000000171; Sharma T., Fong A., Lai T. Surgical treatment for diabetic vitreoretinal diseases: a review. Clin Exp Ophthalmol. 2016;44(4):340–354. DOI:10.1111/ceo.12752; Коновалова К.И., Шишикин М.М., Файзрахманов Р.Р. Эффективность многоэтапного хирургического лечения диабетической ретинопатии, осложненной начальной катарактой. Вестник офтальмологии. 2020;136(6-2):171–176. DOI:10.17116/oftalma2020136062171; Gupta B., Sivaprasad S., Wong R. Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: The Drive UK study. Eye (Lond). 2012;26:510–516. DOI:10.1038/eye.2011.321; Iyer S., Regan K., Burnham J. Surgical management of diabetic tractional retinal detachments. Surv Ophthalmol. 2019;64(6):780–809. DOI:10.1016/j.survophthal.2019.04.008; Stewart M., Browning D., Landers M. Current management of diabetic tractional retinal detachments. Indian J Ophthalmol. 2018;66(12):1751–1762. DOI:10.4103/ijo.IJO_1217_18; Kikushima W., Imai A., Hirano T. Quick Referral and Urgent Surgery to Preempt Foveal Detachment in Retinal Detachment Repair. Asia Pac J of Ophthalmol. 2014;3(3):141–145. DOI:10.1097/APO.0b013e3182a81240; Brănişteanu D., Bilha A., Moraru A. Vitrectomy surgery of diabetic retinopathy complications. Rom J Ophthalmol. 2016;60(1):31–36.; Hu X., Liu H., Wang L. Efficacy and safety of vitrectomy with internal limiting membrane peeling for diabetic macular edema: a meta-analysis. Int J Ophthalmol. 2018;11(11):1848–1855. DOI:10.18240/ijo.2018.11.18; Jackson T., Nicod E., Angelis A. Pars plana vitrectomy for diabetic macular edema. A Systematic Review, Meta-Analysis, and Synthesis of Safety Literature. Retina. 2017;37(5):886–895. DOI:10.1097/IAE.0000000000001280; Simunovic M., Hunyor A., Ho I. Vitrectomy for diabetic macular edema: a systematic review and meta-analysis. Can J Ophthalmol. 2014;49(2):188–195. DOI:10.1016/j.jcjo.2013.11.012; Adelman R., Parnes A., Michalewska Z. Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study. BioMed Research International. 2015; 2015:352487. DOI:10.1155/2015/352487; Farouk M., Naito T., Sayed K. Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249:369–376. DOI:10.1007/s00417-010-1506-7; Chen W., Lin C., Ko P. In vivo confocal microscopic findings of corneal wound healing after corneal epithelial debridement in diabetic vitrectomy. Ophthalmology. 2009;116:1038–1047. DOI:10.1016/j.ophtha.2009.01.002; Holekamp N., Bai F., Shui Y. Ischemic diabetic retinopathy may protect against nuclear sclerotic cataract. Am J Ophthalmol. 2010;150(4):543–550. DOI:10.1016/j.ajo.2010.05.013; Khuthaila M., Hsu J., Chiang A. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2013;155(4):757–763. DOI:10.1016/j.ajo.2012.11.004; Lee B., Yu H. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy. Retina. 2010;30(10):1671–1677. DOI:10.1097/IAE.0b013e3181dcfb79; Jackson T., Johnston R., Donachie P. The Royal College of Ophthalmologists’ national ophthalmology database study of vitreoretinal surgery: Report 6, diabetic vitrectomy. JAMA Ophthalmology. 2016;134(1):79–85. DOI:10.1001/jamaophthalmol.2015.4587; Ehrlich R., Goh Y., Ahmad N., Polkinghorne P. Retinal breaks in small-gauge pars plana vitrectomy. Am J Ophthalmol. 2012;153(5):868–872. DOI:10.1016/j.ajo.2011.10.015; Koreen L., Yoshida N., Escariao P. Incidence of risk factors for, and combined mechanism of late-onset openangle glaucoma after vitrectomy. Retina. 2012;32(1):160– 167. DOI:10.1097/IAE.0b013e318217fffb; Lalezary M., Kim S.J., Jiramongkolchai K., Recchia F.M., Agarwal A., Sternberg J.P. Long-term trends in intraocular pressure after pars plana vitrectomy. Retina. 2011;31(4):679–685. DOI:10.1097/IAE.0b013e3181ff0d5a; Yau G., Silva P., Arrigg P. Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease. Semin Ophthalmol. 2018;33(1):126–133. DOI:10.1080/08820538.2017.1353832; Tao Y., Jiang Y., Li X. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment. Retina. 2010;30:447–451. DOI:10.1097/IAE.0b013e3181d374a5; Rodríguez M., Pérez S., Mena-Mollá S. Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies. Oxid Med Cell Longev. 2019;2019:4940825. DOI:10.1155/2019/4940825; Mitchell P., Bandello F., Schmidt-Erfurth U. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615–625. DOI:10.1016/j.ophtha.2011.01.031; Bressler S.B., Melia M., Glassman A.R. Diabetic Retinopathy Clinical Research Network. Ranibizumab plus prompt or deferred laser for diabetic macular edema in eyes with vitrectomy before anti-vascular endothelial growth factor therapy. Retina. 2015;35:2516–2528. DOI:10.1097/IAE.0000000000000617; Laugesen C., Ostri C., Brynskov T. Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes. Acta Ophthalmol. 2017;95(1):28–32. Accessed July 30, 2016. DOI:10.1111/aos.13160; Elhamid A., Mohamed A., Khattab A. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial. BMC Ophthalmol. 2020;20(1):130. Accessed April 6, 2020. DOI:10.1186/s12886-020-01401-4; https://www.ophthalmojournal.com/opht/article/view/1649
-
2Academic Journal
Authors: Измайлов, Александр, Балашевич, Леонид
Subject Terms: ДИАБЕТИЧЕСКАЯ РЕТИНОПАТИЯ, НЕОВАСКУЛЯРИЗАЦИЯ СЕТЧАТКИ, ПАНРЕТИНАЛЬНАЯ ЛАЗЕРКОАГУЛЯЦИЯ
File Description: text/html
-
3Academic Journal
Source: Офтальмологические ведомости.
Subject Terms: ДИАБЕТИЧЕСКАЯ РЕТИНОПАТИЯ, НЕОВАСКУЛЯРИЗАЦИЯ СЕТЧАТКИ, ПАНРЕТИНАЛЬНАЯ ЛАЗЕРКОАГУЛЯЦИЯ
File Description: text/html
